Each 1g of Enstilar Foam contains:
Calcipotriol 50 micrograms, as calcipotriol monohydrate
Betamethasone 0.5mg, as betamethasone dipropionate
Other ingredients include:
Liquid paraffin
Polyoxypropylene stearyl ether
All-rac-alpha-tocopherol
White soft paraffin
Butylhydroxytoluene (E321)
Butane
Dimethyl ether
Butylhydroxytoluene may cause local skin reactions or irritation to the eyes and mucous membranes.
Enstilar 50 Micrograms/g + 0.5mg/g Cutaneous Foam
Dosage: Calcipotriol 50 micrograms/g + Betamethasone 0.5mg/g
Pack size: 60g 120g (2 × 60g cans)
Manufacturer: LEO Pharma / LEO Laboratories Ltd
Prescription required
Enstilar Cutaneous Foam is a prescription treatment for psoriasis vulgaris in adults.
It contains two active ingredients:
Calcipotriol, a vitamin D analogue that helps slow the excessive production of skin cells associated with psoriasis.
Betamethasone dipropionate, a potent corticosteroid that helps reduce inflammation, redness, itching and swelling.
The foam formulation is designed to spread easily over affected areas and can be used on the body and scalp where prescribed.
Active ingredients: Calcipotriol 50 micrograms/g + Betamethasone 0.5mg/g
Available packs: 60g and 120g (2 × 60g)
Form: Cutaneous foam
Medicine type: Prescription Only Medicine (POM)
Treatment is subject to an appropriate clinical assessment and prescription.
Each 1g of Enstilar Foam contains:
Calcipotriol 50 micrograms, as calcipotriol monohydrate
Betamethasone 0.5mg, as betamethasone dipropionate
Other ingredients include:
Liquid paraffin
Polyoxypropylene stearyl ether
All-rac-alpha-tocopherol
White soft paraffin
Butylhydroxytoluene (E321)
Butane
Dimethyl ether
Butylhydroxytoluene may cause local skin reactions or irritation to the eyes and mucous membranes.
